SPAC Overview
Timeline Progress
- Registration2005-06-09 Filed S1
- IPOWaiting on IPO
- Definitive AgreementNo merger agreement yet
- CompletedNot yet completed
About
A blank-check company seeking to acquire an operating business, with an intended focus on companies or high-volume brands in the over-the-counter pharmaceutical and health and beauty aids industries.
Investment Focus
Biopharmaceuticals, Beauty
The terms and the filing trail behind Pharmamatrix Acquisition CORP
What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.
- Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
- Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
- The full 8-K lifecycle timeline, each event linked to its filing
- Price history across the unit, share and warrant tickers
- Follow it, and see it change on your watchlist
SPAC Team
Leadership
Underwriters
Extended Team Information
Management describes extensive pharmaceutical-industry experience as pharmacists, businessmen and entrepreneurs. Norman M. Meier led a medical marketing and advertising company, while Steven Girgenti chaired and served as CEO of Ogilvy Healthworld; other team members had long pharmaceutical-industry careers, pharmacy experience, and entrepreneurial success.